Atara Biotherapeutics (ATRA) vs enGene Therapeutics (ENGN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Atara Biotherapeutics (ATRA) has outperformed enGene Therapeutics (ENGN) over the past year, losing 40.1% versus a loss of 75.1%. enGene Therapeutics is the larger company by market cap ($114.3 million vs $90.9 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ATRA | ENGN |
|---|---|---|
| Share price | $9.06 | $1.71 |
| Market cap | $90.94M | $114.26M |
| 1-day change | -3.31% | -2.29% |
| YTD return | -48.20% | -80.68% |
| 1-year return | -40.05% | -75.11% |
| 5-year return | -97.52% | — |
| Forward P/E | 5.86 | — |
| EPS (TTM) | $-1.30 | $-2.07 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $19.15 | $12.25 |
| 52-week low | $3.92 | $1.40 |
| Distance from 52-week high | -52.68% | -86.08% |
| Average volume | 54.11K | 746.58K |
| Shares outstanding | 10.04M | 67.02M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ATRA has outperformed ENGN by 35.1 percentage points over the past year.
ATRA vs ENGN FAQ
Which is bigger, Atara Biotherapeutics or enGene Therapeutics?
enGene Therapeutics (ENGN) is larger, with a market capitalization of $114.26M compared with $90.94M for Atara Biotherapeutics (ATRA).
Which stock has performed better over the past year, ATRA or ENGN?
ATRA returned -40.05% over the past 12 months, compared with -75.11% for ENGN (price return, excluding dividends). Past performance does not predict future results.
Are Atara Biotherapeutics and enGene Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.